VistaGen Therapeutics

3 followers


VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for multiple CNS diseases and disorders with high unmet need.

Industries

Headquarters

Stage

Employees

Links

Org chart

Shawn K. Singh
CEO & Director

Shawn K. Singh

Collapse
Reid Adler
Chief Legal Officer
Jessica R. Haskell
VP, Associate General Counsel & Secretary
Mark J. Ginski
SVP, Head of CMC
Allen Cato III
SVP, Development Operations
Trisha Fitzmaurice
SVP, Human Resources
Joshua Prince
VP, Strategic Insights & Analytics
Greg Weilersbacher
VP, Quality Assurance
Louis Monti
VP, Translational Medicine
Ross A. Baker
VP, Global Medical Affairs
Mark Flather
VP, Investor Relations
Mark A. McPartland
VP, Corporate Development
Ester Salmán
VP, Clinical Research
Imogene Dunn
VP, Biostatistics
Margie Schneider
Director, Clinical Supply Chain